RxDoctor Payments Data

Jamie Chao, MD

Urogynecology and Reconstructive Pelvic Surgery · West Allis, WINPI 1811156185

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,447 of the $4,451 with a category attached, or 77.4%. 6 manufacturers reported payments, led by Boston Scientific at 58.6% of the total. Reporting peaked in 2019 at $2,257 and has fallen 76.6% since, to $529 in 2025.

$4,451in general payments, 2019–2025

Across 42 payments — averaging $105.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Medtronic$882
  • Caldera Medical, Inc$577
  • Axonics, Inc.$230
  • AbbVie$136
  • Intuitive Surgical$20

What the payments were for

  • Travel & lodging$86820%
  • Food & beverage$3,44777%
  • Gifts$421%
  • Entertainment$942%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific23$2,607
Medtronic(2 entities)12$882
Caldera Medical, Inc3$577
Axonics, Inc.2$230
AbbVie1$136
Intuitive Surgical1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,451 in reported general payments places this provider in the 55th percentile of 25 urogynecology and reconstructive pelvic surgery providers in Wisconsin.

See all urogynecology and reconstructive pelvic surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$97,109
Medicare patients
197
Services billed
4,820

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron315$207,609
GemtesaVibegron43$24,562
Trospium Chloride ErTrospium Chloride49$8,298
Estradiol96$6,644
Trospium Chloride83$5,135
Methenamine Hippurate71$4,657
Cephalexin128$1,082
Cefdinir81$1,061
Solifenacin Succinate28$804
Trimethoprim11$756
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst66$597
Clobetasol Propionate15$517
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim60$188
Ciprofloxacin Hcl30$141
Ibuprofen28$82

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in West Allis

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →